Table 3 Glucocorticoid and cardiac medications and respiratory data for DMD subjects at time of CMR
DMD Subject | Glucocorticoid/ Cardiac Medications | FVC% | FEV1% | Nighttime support | Restrictive lung disease |
|---|---|---|---|---|---|
1 | Deflazacort | 76 % | 83 % | None | None |
2 | Prednisone, Lisinopril | 54 % | 44 % | None | Mild to moderate |
3 | Lisinopril | 57 % | 58 % | BiPAP | Mild |
4 | Lisinopril | 55 % | 65 % | None | Mild |
5 | Prednisone | 116 % | 115 % | None | None |
6 | Prednisone | 27 % | 32 % | BiPAP | Severe |
7 | Deflazacort | 61 % | 67 % | BiPAP | Moderate |
8 | Prednisone, Perindopril | 55 % | 59 % | None | Moderate |
9 | Prednisone, Lisinopril | 57 % | 54 % | None | Mild to moderate |
10 | Prednisolone | 72 % | 71 % | None | Mild |
11 | None | 79 % | 61 % | None | Mild |
12 | Prednisone, Perindopril | 60 % | 67 % | None | Mild to moderate |
13 | Deflazacort | 121 % | 111 % | None | None |
14 | Prednisone | 92 % | 92 % | None | None |
15 | Prednisolone | 102 % | 106 % | None | None |
16 | Prednisone, Lisinopril | 58 % | 67 % | BiPAP | Mild to moderate |
17 | Prednisolone | 94 % | 105 % | None | None |
18 | Prednisone, Perindopril | 74 % | 86 % | BiPAP | Mild |
19 | Deflazacort, Lisinopril | 104 % | 93 % | None | None |
20 | Prednisone, Lisinopril | 46 % | 50 % | BiPAP | Moderate to severe |